Shares of Bio-Reference Laboratories (BRLI -9.5%) get hammered, despite its FQ3 beating on its...

|About: Bio-Reference Laboratories,... (BRLI)|By:, SA News Editor

Shares of Bio-Reference Laboratories (BRLI -9.5%) get hammered, despite its FQ3 beating on its bottom line earlier today. Net earnings rose 25% Y/Y, as the clinical-testing company's streak of double-digit revenue growth continued, but investors appear to be taking advantage of near 52-week highs to lock in profits as sales growth shows signs of stagnating.